STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
“By approaching them with a long-term commitment and by serving an increasing number of hospitals with advanced solutions within oncology and neurosurgery, including education and training, Elekta can contribute to making the most advanced cancer care available to more patients.” At a Capital Markets Day with focus on emerging markets, Elekta’s (STO:EKTAB) President and CEO, Tomas Puusepp, described how Elekta will build on its leading position in emerging markets. Elekta has a long-term commitment in making the highest standard of cancer care available to more patients throughout the world.
